StreetAlpha.app
Home › Stocks › TELA

TELA Bio, Inc. (TELA)

$0.69
▼ −5.27%
LAST CLOSE · NOV 20

TELA Bio makes soft tissue repair matrices used by surgeons for hernia repair and plastic and reconstructive surgery. It last closed at $0.69 on Nov 20, down 5.27% on the day. The next earnings report for TELA is expected around Tue, Mar 23, 2027, after the close. For the quarter ended Sep 2026, TELA reported EPS of -$0.16 on revenue of $19.0M, with revenue down 8.4% from a year ago. Over its last 8 reports the stock moved an average of 15.7% the session after earnings. Over the last 12 months TELA insiders bought $186K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is TELA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TELA.

Key Stats

Last 12 months
Results
Revenue
$78.2M
+1.5% vs a year ago
Net income
−$41.9M
−53.6% margin
EPS (diluted)
−$0.74
Free cash flow
−$34.4M
−44.0% margin
Valuation
Market cap
$31.1M
45.2M shares
P/E
–
No P/E while losing money
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$22.7M
At Sep 30
Debt
$56.1M
At Jun 30
Shareholder equity
−$24.6M
Shares outstanding
45.2M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $29.5M$29.5MFY2021FY2022: $41.4M$41.4MFY2022FY2023: $58.5M$58.5MFY2023FY2024: $69.3M$69.3MFY2024FY2025: $80.3M$80.3MFY2025

From TELA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Mar 23
Estimated date · After the close
Reported EPS
-$0.16
Quarter ended Sep 2026
Year ago EPS
-$0.19
Same quarter last year
Revenue
$19.0M
−8.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.17Dec '24Mar 2025: -$0.25Mar '25Jun 2025: -$0.22Jun '25Sep 2025: -$0.19Sep '25Dec 2025: -$0.17Dec '25Mar 2026: -$0.21Mar '26Jun 2026: -$0.20Jun '26Sep 2026: -$0.16Sep '26Latest -$0.16
Revenue by quarter
Dec 2024: $17.6MDec '24Mar 2025: $18.5MMar '25Jun 2025: $20.2MJun '25Sep 2025: $20.7MSep '25Dec 2025: $20.9MDec '25Mar 2026: $19.1MMar '26Jun 2026: $19.3MJun '26Sep 2026: $19.0MSep '26Latest $19.0M
How TELA moved after its last 8 reports
Average move the session after a report ±15.7%
Nov 10, 2026After the close+17.7%
Aug 10, 2026After the close−15.1%
Apr 30, 2026After the close+13.1%
Mar 24, 2026After the close−9.3%
Nov 13, 2025After the close−10.0%
Aug 11, 2025After the close−14.0%
May 8, 2025After the close+9.0%
Mar 20, 2025After the close−37.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TELAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on TELA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TELA

Technical Analysis

TELA · as of the Nov 20 close · updated each morning
Turning down, nearing oversold

The stock is 21% below its 20 day and 48% below its 50 day average. It is 23% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the swing low (Jun 26) at $0.67, and the nearest resistance the Pivot at $0.72.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 16.8%/day
Key levels
$1.5052 week high+117.4%
$1.0250 day average+47.8%
$0.89100 day average+29.0%
$0.85200 day average+23.2%
$0.8320 day average+20.3%
$0.80Swing high (Jul 23)+15.9%
$0.77Pivot R1+11.6%
$0.72Pivot+4.3%
$0.69Last close
$0.67Swing low (Jun 26)−2.9%
$0.64Pivot S1−7.2%
$0.5052 week low−27.5%
Indicators
RSI (14)35.40Weak, oversold below 30Neutral
MACD-0.07Below its signal lineBearish
Stochastic19.4Near the bottom of its rangeOversold
ADX (14)13.2No clear trend
Williams %R-92.3Oversold below −80, overbought above −20Oversold
CCI (20)-142.4Oversold below −100, overbought above 100Oversold
Rate of change−16.0%Change over 10 sessionsBearish
ATR (14)$0.12Typical daily range, 16.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TELA

What happened before

See how TELA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TELA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TELA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TELAHow many large options trades hit TELA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

TELA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲22 buying vs 12 selling
  • ▼Held by funds -11.9 pts
  • ▲Funds holding +3
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4845+6.7%
In funds' top 10110.0%
Held by funds58.1%70.0%−11.9 pts
New / increased8 / 149 / 12+4.8%
Reduced / sold out6 / 610 / 1+9.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TELA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TELA Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$186K4 buys · 2 insiders
Sold$00 sales · 0 insiders
2026-08 bought $19K2026-09 bought $167KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 17Joseph H CapperDirectorBuy75,000$1.18$89K
Sep 15Joseph H CapperDirectorBuy75,000$1.05$78K
Aug 17Heather C GetzCEOBuy12,500$0.66$8K
Aug 14Heather C GetzCEOBuy15,000$0.70$10K
Nov 17, 2025EW Healthcare Partners Fund 2-UGP, LLC10% ownerBuy3,604,000$1.11$4.0M
Every insider buy and sale for TELA over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TELA insider trades →

From SEC Form 4 filings by TELA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TELA is in one of them and how their past TELA trades turned out.

TELA in the AI portfolios
Loading…

TELA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TELA in an article yet. Here's the latest on the wider market.

TELA in the news

About TELA Bio

TELA Bio is a medical technology company based in Malvern, Pennsylvania. It sells soft tissue reconstruction products, mainly tissue matrices that surgeons use to repair hernias and to reinforce tissue in plastic and reconstructive surgery. The matrices are made from sheep tissue combined with polymer materials and are sold mainly to surgeons and hospitals in the United States and Europe. The company also distributes some complementary surgical products made by other manufacturers.

Headquarters
Malvern, PA